Regentis Biomaterials' Series C Round

Regentis Biomaterials raised a round of funding on May 14, 2012.

Regentis Biomaterials is focused on developing and commercializing hydrogels for tissue regeneration. The Gelrin hydrogel platform is a matrix of polyethylene glycol diacrylate (PEG-DA) and denatured …

Articles about Regentis Biomaterials' Series C Round: